Tidal Investments LLC Has $1.31 Million Stock Holdings in Walgreens Boots Alliance, Inc. (NASDAQ:WBA)

Tidal Investments LLC grew its position in Walgreens Boots Alliance, Inc. (NASDAQ:WBA - Free Report) by 41.1% in the 4th quarter, according to its most recent filing with the Securities & Exchange Commission. The firm owned 139,982 shares of the pharmacy operator's stock after buying an additional 40,769 shares during the period. Tidal Investments LLC's holdings in Walgreens Boots Alliance were worth $1,306,000 at the end of the most recent quarter.

Other large investors have also made changes to their positions in the company. Golden State Wealth Management LLC acquired a new position in Walgreens Boots Alliance in the fourth quarter valued at about $26,000. Riverview Trust Co lifted its holdings in shares of Walgreens Boots Alliance by 123.8% during the 4th quarter. Riverview Trust Co now owns 2,874 shares of the pharmacy operator's stock valued at $27,000 after purchasing an additional 1,590 shares in the last quarter. Colonial Trust Co SC grew its position in shares of Walgreens Boots Alliance by 79.5% in the 4th quarter. Colonial Trust Co SC now owns 2,928 shares of the pharmacy operator's stock valued at $27,000 after purchasing an additional 1,297 shares during the period. Venturi Wealth Management LLC acquired a new position in shares of Walgreens Boots Alliance in the 4th quarter valued at approximately $28,000. Finally, Independence Bank of Kentucky bought a new stake in Walgreens Boots Alliance during the 4th quarter worth approximately $39,000. Institutional investors own 58.59% of the company's stock.

Insider Transactions at Walgreens Boots Alliance

In other Walgreens Boots Alliance news, Chairman Stefano Pessina bought 832,258 shares of Walgreens Boots Alliance stock in a transaction dated Sunday, April 27th. The stock was bought at an average cost of $11.01 per share, for a total transaction of $9,163,160.58. Following the purchase, the chairman now owns 145,621,079 shares of the company's stock, valued at $1,603,288,079.79. The trade was a 0.57% increase in their position. The purchase was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. 17.50% of the stock is owned by company insiders.

Wall Street Analysts Forecast Growth

A number of research analysts have weighed in on WBA shares. Wall Street Zen initiated coverage on shares of Walgreens Boots Alliance in a research note on Wednesday, May 21st. They issued a "hold" rating on the stock. Wolfe Research raised shares of Walgreens Boots Alliance to a "hold" rating in a research report on Monday, February 24th. Deutsche Bank Aktiengesellschaft lowered shares of Walgreens Boots Alliance from a "hold" rating to a "sell" rating and reduced their target price for the stock from $11.00 to $9.00 in a research note on Friday, February 28th. Finally, Truist Financial dropped their price target on Walgreens Boots Alliance from $13.00 to $12.00 and set a "hold" rating on the stock in a research note on Friday, January 31st. Four equities research analysts have rated the stock with a sell rating, seven have given a hold rating and two have assigned a buy rating to the company. According to data from MarketBeat.com, the company presently has an average rating of "Hold" and an average target price of $10.59.

Walgreens Boots Alliance Stock Up 0.2%

NASDAQ WBA traded up $0.03 during trading hours on Friday, hitting $11.27. 1,935,972 shares of the company traded hands, compared to its average volume of 20,745,687. The company has a debt-to-equity ratio of 0.68, a quick ratio of 0.30 and a current ratio of 0.64. The business's 50-day moving average is $11.03 and its 200-day moving average is $10.46. The stock has a market capitalization of $9.74 billion, a price-to-earnings ratio of -1.10, a P/E/G ratio of 1.31 and a beta of 0.77. Walgreens Boots Alliance, Inc. has a twelve month low of $8.08 and a twelve month high of $16.34.

Walgreens Boots Alliance (NASDAQ:WBA - Get Free Report) last released its quarterly earnings data on Tuesday, April 8th. The pharmacy operator reported $0.63 EPS for the quarter, beating the consensus estimate of $0.53 by $0.10. The company had revenue of $38.59 billion during the quarter, compared to the consensus estimate of $37.90 billion. Walgreens Boots Alliance had a positive return on equity of 17.61% and a negative net margin of 5.87%. The firm's revenue for the quarter was up 4.1% compared to the same quarter last year. During the same quarter in the prior year, the firm posted $1.20 EPS. Sell-side analysts anticipate that Walgreens Boots Alliance, Inc. will post 1.6 earnings per share for the current year.

About Walgreens Boots Alliance

Walgreens Boots Alliance, Inc operates as a healthcare, pharmacy, and retail company in the United States, the United Kingdom, Germany, and internationally. It operates through three segments: U.S. Retail Pharmacy, International, and U.S. Healthcare. The U.S. Retail Pharmacy segment engages in operation of the retail drugstores, health and wellness services, specialty, and home delivery pharmacy services, which offers health and wellness, beauty, personal care and consumables, and general merchandise.